Division of Hematology and Oncology at Howard University Hospital

The Center for Hematology and Oncology at Howard University Hospital provides advanced care for patients with cancer and blood disorders regardless of social and insurance status. Our Cancer Center staff includes:

  • Certified nurses
  • Nurse practitioners
  • Social work support
  • Genetic counselors
  • Patient navigators

We work with specialists throughout the Howard University Hospital to provide comprehensive multidisciplinary and therapeutic plans of care individualized to meet the needs of each patient and their families.

Conditions We Treat

Our doctors have expert knowledge in both benign (non-cancer) and malignant (cancer) tumors. Conditions we treat include:

Solid tumors

Solid tumors may or may not be cancers. They include tumors of the:

  • Breast
  • Prostate
  • Colon
  • Lung
  • Reproductive system (vagina, uterus, ovaries)

Malignant blood-related disorders

  • Lymphoma – cancer of the lymphatic system
  • Multiple myeloma – cancer of the plasma cells
  • Leukemia – cancer of the bone marrow)
  • Mylodyslastic syndrome – also known as bone marrow failure disorder

Sickle cell anemia

Sickle cell anemia is a disorder of the red blood cells. The Center for Hematology and Oncology offers treatments that can improve symptoms and help patients lead healthier, more productive lives.

Other benign blood-related disorders

Some blood disorders do not result in cancer, but affect a patient's quality of life. These include:

  • Anemia
  • Paroxysmal nocturnal hemoglobinuria
  • Thrombocytopenia

Myeloproliferative disorders

Myeloproliferative disorders occurs when the body produces too many cells in the bone marrow. Conditions we treat include:

  • Polycythemia vera
  • Essential thrombocytosis
  • Chronic myeloid leukemia
  • Systemic mastocytosis
  • Myelofibrosis

Coagulation disorders

Coagulation disorders prevent blood from clotting.

Programs & Services

Our board-certified disease specialists handle complex management and treatment-related matters of blood disorders and cancer. We also assist patients in coordinating specialty care services.

Programs and services include:

Howard University Cancer Center

The Howard University Cancer Center provides research, education and service for cancers that affect primarily African American populations. We excel in translational bench-to-bedside research that improves the lives of minorities and underserved populations.

Center for Sickle Cell Disease

The Center for Sickle Cell Disease at Howard University provides services in a multi-specialty setting at the Center, including:

  • Educational programs
  • Community awareness events
  • Screenings for children, collegiate student athletes and adults

Adult Sickle Cell Disease Clinic

The Center for Sickle Cell Disease offers a weekly adult sickle cell disease outpatient clinic for adults with sickle cell disease.

Hours of Operation

Tuesday: 8 a.m. – noon
Appointments: (202) 856-4700

Nurse coordinator: Catherine Nwokolo
Phone: (202) 865-7592

During clinic hours, questions can be directed to (202) 865-1376.

For after-hours inquiries, please call Howard University Hospital at (202) 865-6100 and ask to speak to the hematology fellow on call.

Howard University Hospital
First Floor, Suite C
2041 Georgia Avenue, NW
Washington, DC 20060

Pediatric Sickle Cell Disease Services

The Pediatric Sickle Cell Disease Program works in collaboration with the District of Columbia Greater Access to Pediatric Sickle Cell Services Project. We schedule appointments with pediatric patients three days a week.

Scheduling Appointments/Contact
Please call (202) 865-4583 for further information.

Sickle Cell Patient Screening

Screening for sickle cell disease is offered free of charge. Screening results are generally available within one week. Educational materials are also provided during these hours.

Hours of Operation
Every Wednesday morning from 9 a.m. to noon.

Please call (202) 865-4443 for more information.

Howard University Hospital
First Floor, Suite C
2041 Georgia Avenue, NW
Washington, DC 20060

Families Advocating for Children and Adults with Sickle Cell Disease

Group support meetings are held monthly.

Barbara Harrison, MS
Phone: (202) 806-6329

UFCW, Metro 400 Building
4301 Garden City Drive
Hyattsville, MD 20785

Clinical Research Trials

Patients at the Center for Hematology and Oncology are routinely considered for participation in new and ongoing clinical research trials. Current clinical trials include:

  • Pilot study examining the effective of restorative yoga on sleep.
  • Phase III clinical trial comparing Trastuzumab given concurrently with radiation therapy and radiation therapy alone for women with HER2 positive ductal carcinoma in situ resected by lumpectomy.
  • Phase I and II clinical study of safety and efficacy of Muscadine Plus (MPX) in men with prostate cancer. The study is exploring a randomized dose of the effective of two doses of MPX capsule on rising prostate-specific antigen in men following initial therapy for prostate cancer.
  • Immune monitoring protocol in men with prostate cancer enrolled in a clinical trial of Sipuleucel-T.
  • A registry of Sipuleucel-T therapy in men with advanced prostate cancer.   
  • FIERCE (Focused Intervention on Exercise to Reduce Cancer): A randomized clinical trial targeting African-American women with metabolic syndrome and high risk for breast cancer.
  • Study of prostate cancer work at the molecular level and the gathering of data, in collaboration with the National Genome Center, on unique genetic mutation in African/Black American breast cancer patients to identify clinically significant mutations.

Division of Hematology and Oncology Faculty

Sara Horton, M.D.

Clinical interests include medical oncology, breast cancer, genital and urinary.

Adriana Medina, M.D.

Clinical interests include lung cancer, colon cancer.

Patricia Oneal, M.D.

Clinical interests include benign and malignant hematology.

Zakari Aliyu, M.D.

Clinical interests include hematology/oncology.

Raj Manchandani, M.D.

Clinical interests include hematology/oncology.

Sergei Nekhai, Ph.D.

Focus: research.